Denali 制药 DNLI
$20.07 +$0.35 (+1.77%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $20.16 +0.45%
开盘$19.97
昨收$19.72
当日区间$19.78 – $20.36
成交量1.59M
市值$3.22B
市盈率（TTM）–
股息率–
DNLI 相关新闻
匹配 Denali Therapeutics 或代码 DNLI 的头条新闻，按最新排序。
- A Quick Look at Today's Ratings for Denali Therapeutics(DNLI.US), With a Forecast Between $31 to $42
- A Quick Look at Today's Ratings for Denali Therapeutics(DNLI.US), With a Forecast Between $31 to $41
- B. Riley Securities Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Raises Target Price to $35 正面
- J.P. Morgan Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Maintains Target Price $29
- Morgan Stanley Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Raises Target Price to $36 正面
- Deutsche Bank Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Raises Target Price to $35 正面
- BofA Securities Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Announces Target Price $31
- J.P. Morgan Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Raises Target Price to $29 正面
- H.C. Wainwright Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Maintains Target Price $42
- Wedbush Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Raises Target Price to $26 正面
- UBS Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Maintains Target Price $25
- William Blair Maintains Denali Therapeutics(DNLI.US) With Buy Rating
- Analysts Offer Insights on Healthcare Companies: Agilon Health (AGL), CG Oncology, Inc. (CGON) and Denali Therapeutics (DNLI)
- TD Cowen Maintains Denali Therapeutics(DNLI.US) With Buy Rating
- Wedbush Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Cuts Target Price to $23 负面
暂无评论——快来第一个聊聊 DNLI。
登录后参与讨论。